KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Non-Current Liabilities (2016 - 2026)

Amgen has reported Total Non-Current Liabilities over the past 18 years, most recently at $80.6 billion for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities changed 0.49% year-over-year to $80.6 billion; the TTM value through Mar 2026 reached $80.6 billion, changed 0.49%, while the annual FY2025 figure was $79.6 billion, 4.86% down from the prior year.
  • Total Non-Current Liabilities for Q1 2026 was $80.6 billion at Amgen, up from $79.6 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $87.9 billion in Q1 2024 and troughed at $51.3 billion in Q2 2022.
  • A 5-year average of $76.0 billion and a median of $81.0 billion in 2025 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 62.35% in 2023 and later fell 7.94% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $61.2 billion in 2022, then surged by 40.94% to $86.2 billion in 2023, then decreased by 3.05% to $83.6 billion in 2024, then decreased by 4.86% to $79.6 billion in 2025, then rose by 1.26% to $80.6 billion in 2026.
  • Business Quant data shows Total Non-Current Liabilities for AMGN at $80.6 billion in Q1 2026, $79.6 billion in Q4 2025, and $78.3 billion in Q3 2025.